When was Codis founded?

Codis was founded in 1993 and raised its 1st funding round 32 years after it was founded.

How many employees does Codis have?

As of Oct 31, 2026, the latest employee count at Codis is 195.

Is Codis a funded company?

Codis is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Oct 16, 2025.

When was the latest funding round of Codis?

Codis' latest funding was a $***** Seed round on Oct 16, 2025, with participation from 3 investors.

Where does Codis rank among its competitors?

Codis ranks 60th amongst 872 active competitors, of which 60 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Helogen, which secured $7.1M in Sep, 2026.

Who are the top competitors of Codis?

Codis' top competitors include Alloy Therapeutics, Adimab and Simulations Plus. Among them, Helogen secured the most recent funding round in September, 2026.

Codis - 2026 Company Profile, Funding & Competitors

Company Details

Provider of particle engineering and spray drying solutions for pharmaceuticals. It delivers high-performance solutions for the pharmaceutical industry. The company combines particle engineering expertise and advanced spray drying capabilities. It offers proven regulatory performance for its clients.

Key Metrics

Founded Year

1993

Stage

Seed

Latest Funding Round

Seed, Oct 16, 2025, $*****

Investors

1315 Capital & 2 more

Ranked

60^th among 872 active competitors

Employee Count

195 as on Oct 31, 2026

Similar Companies

Alloy Therapeutics & 893 more

View Codis' full profile

Codis has raised funding over 1 round. Its latest funding round was a Seed round on Oct 16, 2025 for $*****. 3 investors participated in its latest round. Codis has 3 institutional investors.

Here is the list of recent funding rounds of Codis:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 16, 2025	2318325	Seed	1063851	8489003	4637722	1458083

Access funding benchmarks and valuations. Sign up today!

View details of Codis's funding rounds and investors

Codis' employee count trend

Codis has 195 employees as of Oct 26. Here is Codis's employee count trend over the years:

Uncover Codis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Codis include Alloy Therapeutics, Adimab and Simulations Plus. Here is the list of Top 10 competitors of Codis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Alloy Therapeutics 2017, Lexington (United States), Series E	Provider of drug discovery services	$157M	8VC, Mubadala & 11 others	69/100
2nd	Adimab 2007, Series F	Developer of yeast based discovery platforms for therapeutic protein engineering	$35.4M	Polaris Partners, SV Health Investors & 10 others	65/100
3rd	Simulations Plus 1996, Lancaster (United States), Acquired	Developer of modeling and simulation software and consulting services provider	-	FDA, NIH & 1 others	60/100
4th	Manifold Bio 2018, United States, Series A	Developer of tissue-targeted therapeutics using in vivo screening and AI design	$78.2M	Playground Global, Triatomic & 8 others	54/100
5th	CILcare 2014, Montpellier (France), Series A	Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus	$42.3M	Shionogi, Galia Gestion & 5 others	54/100
6th	Helogen 2024, Mountain View (United States), Seed	Provider of space-based biomanufacturing and drug discovery services	$7.1M	RRE Ventures, Blisce & 3 others	52/100
7th	Viva Biotech 2006, Shanghai (China), Public	Research services focused on drug discovery and development	-	Temasek, Spinnotec & 3 others	51/100
8th	Superluminal Medicines 2022, Boston (United States), Series B	Generative biological and chemical company focused on drug discovery	$223M	RA Capital Management, BVF Partners & 9 others	51/100
9th	ArcaScience 2018, Paris (France), Seed	Developer of AI models for patient-centric insights in drug development	$7M	The Moon Venture, Kima Ventures & 5 others	51/100
10th	Arctoris 2016, Abingdon (United Kingdom), Seed	Provider of automated wet lab biology research and data generation services	$3.93M	RT, TD Veen & 7 others	51/100
60th	Codis 1993, Seed	Provider of particle engineering and spray drying solutions for pharmaceuticals	-	1315 Capital, Broadoak Capital Partners & 1 others	42/100